South Korea’s successful approach of regimented masking, aggressive testing, and high-tech contact tracing is a blueprint for the U.S. and other democracies.
A South Korean medical diagnostics maker has ramped up production and is aiming to sell millions of virus test kits to the U.S., where cash-strapped states are scrambling for federal funds to buy them.
Osang Healthcare, a South Korean manufacturer and distributor of medical devices, announced that after receiving approval from the FDA on March 18, the cumulative order quantities of COVID-19 test kits had surpassed 10 million.
Osang Healthcare said it has won the U.S. Food and Drug Administration’s approval for emergency use of the test kit for the new coronavirus, which was the first for a Korean firm.
Osang Healthcare’s coronavirus test kits have won an emergency use authorization from regulators in the United States – a first for a Korean company.
In response to an appeal from President Trump, South Korea is set to deliver 600,000 coronavirus testing kits to the U.S. on Tuesday, according to a new report.
Government has delayed order of South Korean kits as they have not been tested, it is claimed
SOFIA (Bulgaria), April 10 (SeeNews) – Bulgaria’s government said on Friday that it has empowered health minister Kiril Ananiev to sign an agreement for the purchase of PCR tests for novel coronavirus disease (COVID-19) testing from South Korea’s Osang Healthcare.
The Health Ministry has announced having allocated two billion dirhams to upgrade its medical devices, including the acquisition of 100,000 testing kits for the coronavirus.
Italian diagnostics firm EliTech Group said on Tuesday that South Korea’s OsangHealthcare has received CE marking for its..